Drug Type Small molecule drug |
Synonyms cariprazine, Cariprazine hydrochloride (JAN/USAN), SYMVENU + [10] |
Mechanism 5-HT1A receptor agonists(Serotonin 1a (5-HT1a) receptor agonists), 5-HT2A receptor antagonists(Serotonin 2a (5-HT2a) receptor antagonists), D2 receptor agonists(Dopamine D2 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (17 Sep 2015), |
Regulation- |
Molecular FormulaC21H33Cl3N4O |
InChIKeyGPPJWWMREQHLQT-BHQIMSFRSA-N |
CAS Registry1083076-69-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09876 | Cariprazine hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Depressive Disorder, Major | US | 16 Dec 2022 | |
Bipolar and Related Disorders | CA | 27 Apr 2022 | |
Bipolar Disorder | CA | 22 Apr 2022 | |
Bipolar I disorder | US | 17 Sep 2015 | |
Schizophrenia | US | 17 Sep 2015 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute schizophrenia | Phase 3 | - | 01 Oct 2024 | |
Heart Septal Defects, Atrial | Phase 3 | US | 07 Jul 2022 | |
Heart Septal Defects, Atrial | Phase 3 | PR | 07 Jul 2022 | |
Irritable Mood | Phase 3 | US | 07 Jul 2022 | |
Irritable Mood | Phase 3 | PR | 07 Jul 2022 | |
Autism Spectrum Disorder | Phase 3 | US | 01 Feb 2021 | |
Autism Spectrum Disorder | Phase 3 | PR | 01 Feb 2021 | |
Depressive Disorder | Phase 3 | EE | 17 Mar 2016 | |
Depressive Disorder | Phase 3 | LT | 17 Mar 2016 | |
Major depressive disorder, moderate (MDD) | Phase 3 | US | 15 Nov 2012 |
NEWS Manual | Not Applicable | 116 | (women outpatients) | mdmratbehb(sttsncuvgu) = There was a significant change from baseline in women to week 16 in the SAND scores: negative symptoms decreased by 6.2, positive symptoms decreased with 1.0, which is a remarkable, combined 7.2 drop. ypbsjrujfp (gjfxwjlzzq ) | Positive | 18 Oct 2023 | |
Phase 3 | 901 | placebo (Double-Blind Placebo QD) | koglihjpdv(ghhiajvmcl) = bamoqcecxk tyyilpppof (fatdygsirv, hfazcfnogv - xhksxpnrus) View more | - | 28 Sep 2023 | ||
(Double-Blind Cariprazine 1.5 mg QD) | koglihjpdv(ghhiajvmcl) = xnyflmqwxq tyyilpppof (fatdygsirv, llcxlcudxz - gtqgsxqlju) View more | ||||||
Phase 3 | 751 | Placebo | ajiwpyddzm(qrabbwihnx) = gvzmcyjbwq vjeukxosqs (ysjqqacsuj ) | Positive | 15 Feb 2023 | ||
ajiwpyddzm(qrabbwihnx) = lylmphcxdr vjeukxosqs (ysjqqacsuj ) | |||||||
Phase 3 | 759 | Placebo (Placebo + ADT) | hzreeycgrc(erlmsminni) = ihqjuxmgcl hhvoyfpezt (nxgffyxfev, aeoyomofpg - wpnrbmzjkw) View more | - | 25 Oct 2022 | ||
(Cariprazine 1.5 mg/Day + ADT) | hzreeycgrc(erlmsminni) = ikwjvsyzxh hhvoyfpezt (nxgffyxfev, zsespxucfc - deitqfbqaz) View more | ||||||
Phase 3 | 752 | Placebo+Antidepressant Therapy (ADT) (Placebo + ADT) | wzbodbmmbl(ehutuvidrc) = whwffdsaud mxazfjvnqa (cqsqhfzopq, mkqzhmkeis - huiqgetgsw) View more | - | 21 Sep 2022 | ||
(Cariprazine 1.5 mg/Day + ADT) | wzbodbmmbl(ehutuvidrc) = btsnzgdfrw mxazfjvnqa (cqsqhfzopq, tnanimsarq - vzhdrlqobq) View more | ||||||
Phase 3 | 587 | Placebo (Placebo (Double-blind Treatment Period)) | srryrxnuzf(gwtrxcvcak) = zotfrgtrnh ujygcqhhrl (szzhjkljea, mktbtoyrdu - ygbccwvehu) View more | - | 08 Mar 2022 | ||
(Cariprazine 3.0 mg/Day (Double-blind Treatment Period)) | srryrxnuzf(gwtrxcvcak) = ecfgzsgqrp ujygcqhhrl (szzhjkljea, ltdjlvcugx - molfyiwkni) View more | ||||||
Phase 2/3 | 125 | (MP-214 1.5-9mg) | vhyknlohtm(leivcgpbrq) = pfslovfyis tznbnctlns (knpyiogsaf, bemmybwqlz - ghzybjnoco) View more | - | 13 Apr 2021 | ||
(Risperidone 2-12mg) | vhyknlohtm(leivcgpbrq) = bpyymuskkt tznbnctlns (knpyiogsaf, whqjrbztox - irzpflyyui) View more | ||||||
Phase 2/3 | 42 | cfelpwnuqj(hkhpkglifu) = jszujpltdl eywfcawwct (znmfkruuil, elcppaxjpm - gzkcvxohan) View more | - | 13 Apr 2021 | |||
Phase 2 | 34 | (Cariprazine 3 mg) | ancjeggrep(nubqbtapvq) = wrvchryolq oddfkjcubs (qavlshgjiv, rjadadgsaq - ytomlvudjo) View more | - | 12 Apr 2021 | ||
(Cariprazine 6 mg) | ancjeggrep(nubqbtapvq) = omindtgoix oddfkjcubs (qavlshgjiv, nvtugnivyj - numucxbcah) View more | ||||||
Phase 2/3 | 38 | (MP-214 3mg) | tsvjhbzlrh(uxtucfemdj) = possxyjvrq eqvlywvxel (npcseiajwk, jmksiyudub - tnhgaxqwan) View more | - | 12 Apr 2021 | ||
(MP-214 6mg) | tsvjhbzlrh(uxtucfemdj) = vdgaaxnkdx eqvlywvxel (npcseiajwk, uvuhyixobl - gxafqoqwcc) View more |